Deferred Tax Assets, Gross in USD of Regen BioPharma Inc from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Regen BioPharma Inc quarterly Deferred Tax Assets, Gross history and change rate from Q1 2014 to Q3 2024.
  • Regen BioPharma Inc Deferred Tax Assets, Gross for the quarter ending 30 Sep 2024 was $4.29M, a 3.38% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.29M +$140K +3.38% 30 Sep 2024 10-K 13 May 2025
Q3 2023 $4.15M -$243K -5.53% 30 Sep 2023 10-K 13 May 2025
Q3 2022 $4.39M -$513K -10.5% 30 Sep 2022 10-K 15 Nov 2022
Q3 2021 $4.9M +$1.42M +40.8% 30 Sep 2021 10-K 22 Dec 2021
Q3 2020 $3.48M -$717K -17.1% 30 Sep 2020 10-K 04 Aug 2021
Q3 2019 $4.2M +$534K +14.6% 30 Sep 2019 10-K 21 Jun 2021
Q4 2018 $3.6M -$1.68M -31.9% 31 Dec 2018 10-Q 12 Feb 2019
Q3 2018 $3.67M -$666K -15.4% 30 Sep 2018 10-K 27 Dec 2018
Q2 2018 $3.46M -$445K -11.4% 30 Jun 2018 10-Q 06 Aug 2018
Q1 2018 $3.5M +$483K +16% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 $5.28M -$2.46M -31.7% 31 Dec 2017 10-Q 06 Feb 2018
Q3 2017 $4.33M -$2.54M -37% 30 Sep 2017 10-K 05 Jan 2018
Q2 2017 $3.91M -$2.14M -35.4% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 $3.02M -$2.23M -42.5% 31 Mar 2017 10-Q 05 May 2017
Q4 2016 $7.73M +$2.86M +58.7% 31 Dec 2016 10-Q/A 28 Apr 2017
Q3 2016 $6.88M +$2.64M +62.1% 30 Sep 2016 10-K/A 28 Apr 2017
Q2 2016 $6.04M +$2.01M +49.7% 30 Jun 2016 10-Q/A 28 Apr 2017
Q1 2016 $5.24M +$1.74M +49.6% 31 Mar 2016 10-Q/A 28 Apr 2017
Q4 2015 $4.87M +$4.36M +857% 31 Dec 2015 10-Q/A 28 Apr 2017
Q3 2015 $4.24M +$3.81M +876% 30 Sep 2015 10-K/A 28 Apr 2017
Q2 2015 $4.04M +$3.67M +995% 30 Jun 2015 10-Q/A 28 Apr 2017
Q1 2015 $3.51M +$3.19M +1023% 31 Mar 2015 10-Q/A 28 Apr 2017
Q4 2014 $509K 31 Dec 2014 10-Q 04 Feb 2015
Q3 2014 $435K 30 Sep 2014 10-K 18 Dec 2014
Q2 2014 $369K 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 $312K 31 Mar 2014 10-Q 05 May 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.